Search by Drug Name or NDC

    NDC 68788-8159-03 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 68788-8159
    Product ID 68788-8159_85199d07-1e48-462a-ab6e-99d3c691f091
    Associated GPIs 36991802550305
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide Tablets
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name Preferred Pharmaceuticals Inc.
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204058
    Listing Certified Through 2024-12-31

    Package

    NDC 68788-8159-03 (68788815903)

    NDC Package Code 68788-8159-3
    Billing NDC 68788815903
    Package 30 TABLET in 1 BOTTLE (68788-8159-3)
    Marketing Start Date 2022-03-24
    NDC Exclude Flag N
    Pricing Information N/A